7498 Results (Page 285 of 300)
Pharmaceuticals Markets Research Reports
India Dental Fluoride Treatment Market Analysis
The India Dental Fluoride Treatment Market was valued at $275.8 Mn in 2023 and is projected to grow at a CAGR of 6.9% from 2023 to 2023, to $440 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. Furthermore, increasing support from the government to improve access to person-cantered treatment and to advance a holistic method of oral health equity has contributed to market growth. The industry is primarily dominated by players such as Colgate, Clove Dental, Himalayas, Dabur and Hindustan Unilever Limited among others.
Malaysia Cold Pain Therapy Market Analysis
The Malaysia Cold Pain Therapy Market was valued at $4 Mn in 2022 and is predicted to grow at a CAGR of 5.4% from 2023 to 2030, to $5 Mn by 2030. The key drivers of this industry include the rising burden of chronic pain disorders, growing consumer preference for non-invasive techniques, and expanded product offerings in the therapeutics industry. The industry is primarily dominated by players such as Duopharma, Phamaniaga, Ossur, Rohto, Pfizer, Hisamitsu, and Johnson & Johnson among others.
Mexico Periodontal Therapeutics Market Analysis
The Mexico Periodontal Therapeutics Market was valued at $13.1 Mn in 2023 and is predicted to grow at a CAGR of 7.45% from 2023 to 2030, to $21.6 Mn by 2030. Mexico Periodontal Therapeutics Market is growing due to Prevalence of periodontitis, Emphasis on Preventive Oral Care, and Shift Towards Minimally Invasive Treatments. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.
Mexico Cold Pain Therapy Market Analysis
The Mexico Cold Pain Therapy Market was valued at $33 Mn in 2022 and is predicted to grow at a CAGR of 5.45% from 2023 to 2030, to $50 Mn by 2030. The key drivers of this industry include the rising burden of pain disorders, expanding product offerings, and growing public awareness. The industry is primarily dominated by players such as DJO Global, Hisamitsu, Medichill, Ossur, Brownmed, Pfizer, and Unexo among others.
France Periodontal Therapeutics Market Analysis
The France Periodontal Therapeutics Market was valued at $24 Mn in 2023 and is predicted to grow at a CAGR of 6.2% from 2023 to 2030, to $36.6 Mn by 2030. France Periodontal Therapeutics Market is growing due to Technological Developments, Rise in Demand for Non-surgical Periodontal Therapies, and Prevalence of periodontitis. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.
Philippines Cold Pain Therapy Market Analysis
The Philippines Cold Pain Therapy Market was valued at $5 Mn in 2022 and is predicted to grow at a CAGR of 5.7% from 2023 to 2030, to $8 Mn by 2030. The key drivers of this industry include a surge in the prevalence of chronic pain disorders, supportive government initiatives, and technological advancements in the therapeutics industry. The industry is primarily dominated by players such as Breg, Polar Product, Ossur, Rohto, Pfizer, Hisamitsu, and Johnson & Johnson among others.
Germany Periodontal Therapeutics Market Analysis
The Germany Periodontal Therapeutics Market was valued at $31.9 Mn in 2023 and is predicted to grow at a CAGR of 5.4% from 2023 to 2030, to $46.2 Mn by 2030. Germany Periodontal Therapeutics Market is growing due to Rising Geriatric Population, Emphasis on Preventive Oral Care, and Advancements in Treatment Technologies. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.
Canada Blood Group Typing Market Analysis
The Canada Blood Group Typing Market was valued at $275.20 Mn in 2023 and is predicted to grow at a CAGR of 9.70% from 2023 to 2030, to $526.13 Mn by 2030. The key drivers of this industry are increase in prevalence of chronic diseases, public initiatives, and rising number of surgical procedures. The key players in the industry are Grifols Canada, BAG Diagnostics GmbH, Roche Diagnostics, and Abbott Laboratories.
Saudi Arabia Cold Pain Therapy Market Analysis
The Saudi Arabia Cold Pain Therapy Market was valued at $37 Mn in 2022 and is predicted to grow at a CAGR of 6.7% from 2023 to 2030, to $63 Mn by 2030. The key drivers of this industry include the rising incidence of pain disorders, increased demand for non-opioid alternatives, and expanding healthcare infrastructure. The industry is primarily dominated by players such as Romsons, Hisamitsu, Rapid Aid, Ossur, Tabuk, Breg, and Pfizer among others.
Spain Periodontal Therapeutics Market Analysis
The Spain Periodontal Therapeutics Market was valued at $16.9 Mn in 2023 and is predicted to grow at a CAGR of 6.2% from 2023 to 2030, to $25.7 Mn by 2030. Spain Periodontal Therapeutics Market is growing due to Prevalence of periodontitis, Emphasis on Preventive Oral Care, and Advancements in Treatment Technologies. The market is primarily dominated by players such as Pfizer Inc., Bausch Health Companies Inc. Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd.
UK Blood Group Typing Market Analysis
The UK Blood Group Typing Market was valued at $89.44 Mn in 2023 and is predicted to grow at a CAGR of 7.70% from 2023 to 2030, to $150.33 Mn by 2030. The key drivers of this industry are rise in geriatric population, technological advancements, and government initiatives. The key players in the industry are Grifols S.A., Ortho Clinical Diagnostics, Merck KGaA, and Abbott Laboratories.
China Alopecia (Hair Loss) Therapeutics Market Analysis
The China Alopecia (Hair Loss) Therapeutics Market was valued at US $0.66 Bn in 2022, and is predicted to grow at (CAGR) of 9% from 2023 to 2030, to US $1.31 Bn by 2030. The key drivers of this industry include the surge in the prevalence of Alopecia (hair loss), increased disposable income, technological advancements and others. The industry is primarily dominated by players such as Johnson & Johnson, Eli Lilly, Merck, Curollax, Lutronic, Pfizer among others.
Singapore Cold Pain Therapy Market Analysis
The Singapore Cold Pain Therapy Market was valued at $3 Mn in 2022 and is predicted to grow at a CAGR of 5.8% from 2023 to 2030, to $4 Mn by 2030. The key drivers of this industry include an upward trend in the prevalence of chronic pain disorders, rising disposable income, and technological advancements in the therapeutics industry. The industry is primarily dominated by players such as Ossur, Medline, Pfizer, Hisamitsu, Johnson & Johnson, and Sanofi among others.
UK Periodontal Therapeutics Market Analysis
The UK Periodontal Therapeutics Market was valued at $22.7 Mn in 2023 and is predicted to grow at a CAGR of 5.2% from 2023 to 2030, to $32.4 Mn by 2030. The UK Periodontal Therapeutics Market is growing due to Rising prevalence of periodontitis, Emphasis on Preventive Oral Care, and Technological Developments. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.
Malaysia Blood Group Typing Market Analysis
The Malaysia Blood Group Typing Market was valued at $5.53 Mn in 2023 and is predicted to grow at a CAGR of 9.90% from 2023 to 2030, to $10.71 Mn by 2030. The key drivers of this industry are increase in prevalence of chronic diseases, public initiatives, and rising number of surgical procedures. The key players in the industry are Grifols S.A., Roche Diagnostics, Quantum Diagnostics, and Thermo Fisher Scientific Inc.
South Africa Cold Pain Therapy Market Analysis
The South Africa Cold Pain Therapy Market was valued at $14 Mn in 2022 and is predicted to grow at a CAGR of 6.43% from 2023 to 2030, to $24 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic pain disorders, supportive government initiatives, and technological advancements in the industry. The industry is primarily dominated by players such as Ossur, Rohto, Pfizer, Hisamitsu, Johnson & Johnson, Sanofi, and Breg among others.
China Periodontal Therapeutics Market Analysis
The China Periodontal Therapeutics Market was valued at $70.2 Mn in 2023 and is predicted to grow at a CAGR of 8.7% from 2023 to 2030, to $125.8 Mn by 2030. China Periodontal Therapeutics Market is growing due to Economic Growth and Rising Disposable Income, Technological Advancements, and Emphasis on Preventive Oral Care. The market is primarily dominated by players such as Chartwell Pharmaceuticals LLC, ASA Dental, Steris-Hu-Friedy, Envista Holding Corporation, and Tokyo Chemical Industry Co. Ltd.
Singapore Blood Group Typing Market Analysis
The Singapore Blood Group Typing Market was valued at $4.13 Mn in 2023 and is predicted to grow at a CAGR of 10.30% from 2023 to 2030, to $8.20 Mn by 2030. The key drivers of this industry are increase in prevalence of chronic diseases, public initiatives, and rising number of surgical procedures. The key players in the industry are Grifols S.A., Parkway Laboratory Services, Raffles Medical Group, and Beckman Coulter Life Sciences.
UAE Cold Pain Therapy Market Analysis
The UAE Cold Pain Therapy Market was valued at $11 Mn in 2022 and is predicted to grow at a CAGR of 6.2% from 2023 to 2030, to $18 Mn by 2030. The key drivers of this industry include an upward trend in the incidence of pain disorders, technological advances in the industry, and supportive government policies. The industry is primarily dominated by players such as Julphar, Hisamitsu, Rapid Aid, Ossur, Zimmer Biomet, Breg, and Pfizer among others.
Indonesia Periodontal Therapeutics Market Analysis
The Indonesia Periodontal Therapeutics Market was valued at $5.2 Mn in 2023 and is predicted to grow at a CAGR of 7.2% from 2023 to 2030, to $8.5 Mn by 2030. Indonesia Periodontal Therapeutics Market is growing due to High Prevalence of periodontitis, Emphasis on Preventive Oral Care, and Advancements in Treatment Technologies. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.
UK Cold Pain Therapy Market Analysis
The UK Cold Pain Therapy Market was valued at $57 Mn in 2022 and is predicted to grow at a CAGR of 3.2% from 2023 to 2030, to $74 Mn by 2030. The key drivers of this industry include the increasing prevalence of chronic pain disorders, technological advances in the industry, and demand for non-invasive pain relief approaches. The industry is primarily dominated by players such as DJO Global, Breg, Beiersdorf, Ossur, Performance Health, Pfizer, and Hisamitsu among others.
Japan Periodontal Therapeutics Market Analysis
The Japan Periodontal Therapeutics Market was valued at $54.2 Mn in 2023 and is predicted to grow at a CAGR of 7.7% from 2023 to 2030, to $91.2 Mn by 2030. Japan Periodontal Therapeutics Market is growing due to Rising Geriatric Population, Emphasis on Preventive Oral Care, and Advancements in Treatment Technologies. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.
Malaysia Periodontal Therapeutics Market Analysis
The Malaysia Periodontal Therapeutics Market was valued at $1.4 Mn in 2023 and is predicted to grow at a CAGR of 7.4% from 2023 to 2030, to $2.3 Mn by 2030. Malaysia Periodontal Therapeutics Market is growing due to Rising Awareness About Dental Hygiene, High Prevalence of periodontitis and Advancements in Treatment method. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.
Vietnam Cold Pain Therapy Market Analysis
The Vietnam Cold Pain Therapy Market was valued at $11 Mn in 2022 and is predicted to grow at a CAGR of 5.43% from 2023 to 2030, to $17 Mn by 2030. The key drivers of this industry include a surge in the prevalence of chronic pain disorders, consumer demand for non-invasive approaches, and the evolving technological landscape in the industry. The industry is primarily dominated by players such as Ossur, Rohto, Pfizer, Hisamitsu, Johnson & Johnson, Sanofi, and Breg among others.
Canada Bone Disease Therapeutics Market Analysis
The Canada Bone Disease Therapeutics Market was valued at $1.296 Bn in 2022 and is predicted to grow at a CAGR of 8.9% from 2023 to 2030, to $2.563 Bn by 2030. The key drivers of this industry include the increasing aging population of Canada, improving government initiatives, technological advancements, and others. The industry is primarily dominated by players such as Roche, Pfizer, Merck, AbbVie, Novartis, Teva, and Johnson & Johnson, among others.
